​

Parabilis Medicines (PBLS) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Parabilis Medicines Revenue Highlights


0

Latest Revenue (Q)

$2.11M

Parabilis Medicines Revenue by Period


Parabilis Medicines Revenue by Year

DateRevenueChange
2025-12-31-100.00%
2024-12-31--

Parabilis Medicines generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Parabilis Medicines Revenue by Quarter

DateRevenueChange
2026-09-30$2.11M1328.38%
2026-06-30$148.00K100.00%
2026-03-31-100.00%
2025-06-30-100.00%
2025-03-31--

Parabilis Medicines generated $2.11M in revenue during Q3 2026, up 1328.38% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Parabilis Medicines Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
MGNXMacroGenics$149.50M$18.67M
GLUEMonte Rosa Therapeutics$123.67M$54.37M
CTMXCytomX Therapeutics$76.20M$1.69M
TNGXTango Therapeutics$62.38M-
FHTXFoghorn Therapeutics$30.91M$83.54M
RLAYRelay Therapeutics$15.36M-
IMNMImmunome$6.94M-
CGEMCullinan Therapeutics--
PBLSParabilis Medicines-$2.11M
CBIOCrescent Biopharma--
ZYMEZymeworks$-27.11M$256.46M

PBLS Revenue FAQ


What is Parabilis Medicines’s yearly revenue?

Parabilis Medicines's yearly revenue for 2025 was $0, representing an increase of 100.00% compared to 2024. The company's yearly revenue for 2024 was $0, representing an increase of 0% compared to 2023.

What is Parabilis Medicines’s quarterly revenue?

Parabilis Medicines's quarterly revenue for Q3 2026 was $2.11M, a 1328.38% increase from the previous quarter (Q2 2026), and a 0% increase year-over-year (Q1 2025). The company's quarterly revenue for Q2 2026 was $148K, a 100.00% increase from the previous quarter (Q1 2026). PBLS's quarterly revenue for Q1 2026 was $0, a 100.00% increase from the previous quarter (Q2 2025).